The cardiac rehabilitation market has seen considerable growth due to a variety of factors.
• Recent years have seen substantial growth in the size of the cardiac rehabilitation market. The market is predicted to increase from $2.18 billion in 2024 to $2.32 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.7%.
Factors contributing to this growth in the historic period include higher instances of unhealthy lifestyle habits, an increase in cardiovascular diseases, a surge in popularity of e-cardiology, a rise in diseases linked to obesity, and a surge in diabetes prevalence.
The cardiac rehabilitation market is expected to maintain its strong growth trajectory in upcoming years.
• The cardiac rehabilitation sector is anticipated to witness robust expansion in the coming years, potentially reaching $2.99 billion by 2029 with an annual growth rate of 6.5%.
This surge during the projected period can be credited to factors such as growing public awareness, government initiatives, an increase in the elderly population, transition to home-based and virtual cardiac rehabilitation programs, a rise in the use of tele-cardiac rehabilitation, and heightened demand for effective preventative methods. During the forecast period, key trends to watch include advancements in remote monitoring systems, the application of artificial intelligence, use of machine learning, new-age exercise equipment, and innovation in wearable tech devices.
An increase in cardiovascular disease incidence is projected to boost the cardiac rehabilitation market's expansion in the future. Cardiovascular diseases (CVDs), which include disorders like coronary artery illness, heart failure, and stroke, impact the heart and blood vessels. The growth in cardiovascular disease incidence can be linked to several elements such as unhealthy eating practices, lack of physical activity, use of tobacco, excessive drinking, air contamination, and socio-economic factors such as poverty and stress. Cardiac rehabilitation involves personalized exercise programs designed to suit each patient's cardiac condition. Regular physical activity is beneficial to heart muscle strengthening, improved circulation, and enhanced overall cardiovascular performance, thus lessening the chances of subsequent heart-related incidents. For example, data from the American Heart Association, a U.S. based non-profit striving for heart disease and stroke-free healthier lives, indicated that in January 2024, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, marking a 4.0% increase from 224.4 per 100,000 in 2023. Thus, the increasing incidence of cardiovascular disease is fueling the cardiac rehabilitation market.
The cardiac rehabilitation market covered in this report is segmented –
1) By Product: Elliptical Trainer, Stabilization ball, Treadmill, Heart Rate Monitor, Blood Pressure Monitor, Rower, Other Products
2) By Disease Type: Percutaneous Coronary Intervention, Myocardial Infarction, Coronary Artery Bypass Grafting, Coronary Artery Disease, Other Disease Types
3) By End-User: Rehab Centers, Hospitals, Clinics, Other End-Users
Subsegments:
1) By Elliptical Trainer: Standard Elliptical Trainers, Recumbent Elliptical Trainers, Compact Elliptical Trainers
2) By Stabilization Ball: Standard Stability Balls, Weighted Stability Balls, Anti-Burst Stability Balls
3) By Treadmill: Manual Treadmills, Motorized Treadmills, Folding Treadmills
4) By Heart Rate Monitor: Chest Strap Monitors, Wrist-Based Monitors, Smartwatch Monitors
5) By Blood Pressure Monitor: Digital Blood Pressure Monitors, Aneroid Blood Pressure Monitors, Ambulatory Blood Pressure Monitors
6) By Rower: Air Resistance Rowers, Water Resistance Rowers, Magnetic Resistance Rowers
7) By Other Products: Resistance Bands, Stationary Bikes, Step Machines, Fitness Trackers
Leading businesses within the cardiac rehabilitation sector are centring their attention on groundbreaking services like the virtual delivery model to better patient accessibility. Through this remote healthcare service, medical programs can be conducted digitally, overcoming geographical and logistic challenges. An illustration of this occurred in January 2023, when Sharecare, a digital health company based in the US, unveiled the Ornish Lifestyle Medicine program. This is an Intensive Cardiac Rehabilitation (ICR) project focused on empowering patients to better their heart health through adjustments in their lifestyle. The primary objective is to boost health results for people beset with cardiovascular disease by affording easier reach to effective cardiac rehabilitation, thereby fostering health equity and bridging the inequality gap.
Major companies operating in the cardiac rehabilitation market are:
• Optum Inc.
• F. Hoffmann-La Roche AG
• AstraZeneca PLC
• Medtronic PLC
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• GE Healthcare Company
• Baxter International Inc.
• Boston Scientific Corporation
• Medline Industries LP
• Omron Corporation
• Zoll Medical Corporation
• Epic Systems Corporation
• Lupin Limited
• ICU Medical Inc.
• Arjo AB
• American Heart Association Inc.
• Technogym S.p.A.
• Life Fitness LLC
• Core Health & Fitness LLC
North America was the largest region in the cardiac rehabilitation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac rehabilitation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.